Lucia B. Jilaveanu, Ph.D.
Affiliations: | 2007 | Wesleyan University, Middletown, CT, United States |
Area:
Molecular Biology, BiochemistryGoogle:
"Lucia Jilaveanu"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Donald B. Oliver | grad student | 2007 | Wesleyan | |
| (Studies of SecA oligomeric state and membrane topology.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Provance OK, Oria VO, Tran TT, et al. (2024) Vascular mimicry as a facilitator of melanoma brain metastasis. Cellular and Molecular Life Sciences : Cmls. 81: 188 |
| Su D, Djureinovic D, Schoenfeld D, et al. (2023) Melanocortin 1 receptor (MC1R) expression as a marker of progression in melanoma. Research Square |
| Schoenfeld DA, Merkin RD, Moutafi M, et al. (2022) Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance. Frontiers in Oncology. 12: 990367 |
| Oria VO, Zhang H, Zito CR, et al. (2022) Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma. Cellular and Molecular Life Sciences : Cmls. 79: 377 |
| Tran TT, Rane CK, Zito CR, et al. (2021) Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells. Cancers. 13 |
| Tran TT, Gallezot JD, Jilaveanu LB, et al. (2020) [C]Methionine and [C]PBR28 as PET Imaging Tracers to Differentiate Metastatic Tumor Recurrence or Radiation Necrosis. Molecular Imaging. 19: 1536012120968669 |
| Weiss SA, Zito C, Tran T, et al. (2020) Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases. Journal of Neuro-Oncology |
| Oria V, Zhang H, Zhu H, et al. (2020) 19. PLEKHA5 REGULATES TUMOR GROWTH IN METASTATIC MELANOMA Neuro-Oncology Advances. 2: ii3-ii3 |
| Zhang H, Zhu H, Deng G, et al. (2019) PLEKHA5 regulates tumor growth in metastatic melanoma. Cancer |
| Damsky W, Jilaveanu L, Turner N, et al. (2019) B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors. Journal For Immunotherapy of Cancer. 7: 153 |